Trodelvy® is now FDA-approved as a first-line treatment option for patients with metastatic triple-negative breast cancer, expanding its role in frontline care. Gilead Sciences has secured a major new U.S.…
Carnegie Mellon-Led Team Secures Up to $39.3 Million ARPA-H Award to Develop OMEGA Fetal Monitoring System Carnegie Mellon University is spearheading a major multi-institution research initiative aimed at transforming how…
TRYNGOLZA® becomes the first and only FDA-approved treatment for severe hypertriglyceridemia, reducing both triglyceride levels and the risk of acute pancreatitis. Ionis Pharmaceuticals has secured a major regulatory milestone with…
Pfizer’s IBRANCE Wins FDA Approval in HR+/HER2+ Metastatic Breast Cancer, Expanding CDK4/6 Use Into New Maintenance Setting Pfizer has secured a significant new U.S. regulatory milestone for IBRANCE (palbociclib), with…
AL-S Pharma Presents Phase 2 AP-101 Data at ENCALS 2026, Highlighting Potential Disease-Modifying Effects in ALS AL-S Pharma AG, a clinical-stage biotechnology company focused on developing antibody therapies against misfolded…
AstraZeneca and YMCA of the USA Launch Five-Year Partnership to Expand Cancer Screening, Early Detection and Survivorship Support Across the U.S. AstraZeneca and YMCA of the USA (Y-USA) have announced…
New Reproducibility Standard Set for Breast Imaging Biomarkers QT Imaging Holdings, Inc., a medical device company focused on advancing breast health through radiation-free imaging technology, has reported new data characterizing…
EMD Serono Names Miguel Fernández Alcalde Head of Global Commercial Strategy, Appoints Monia Vial to Lead North America EMD Serono, the Healthcare business of Merck KGaA in the United States…
Anodyne Nanotech Raises $12.6 Million Series A to Advance Weekly GLP-1 Patch for Obesity and Expand Transdermal Drug Delivery Platform Anodyne Nanotech Inc., a clinical-stage biotechnology company focused on transforming…
CEL-SCI and Saudi Amarox Formalize Partnership at BIO 2026 to Advance Oncology Innovation in Saudi Arabia CEL-SCI Corporation announced that it has officially completed a formal signing ceremony with Saudi…
Javelin Biotech Publishes Multi-Tissue Chip and PBPK Study Showing Potential to Predict Human Drug Pharmacokinetics Without Animal Data Javelin Biotech has announced the publication of a new scientific study that…
HighRes and Waters Biosciences Partner to Bring Robotic Automation to Flow Cytometry Workflows HighRes has announced a strategic collaboration with Waters Biosciences aimed at expanding robotic automation capabilities for flow…